THE EFFECT OF ATROMID-S ON THE FIBRINOLYTIC ENZYME SYSTEM.
D000738:Androsterone; D000924:Anticholesteremic Agents; D001162:Arteriosclerosis Obliterans; D002087:Butyrates; D002784:Cholesterol / Q000097:blood*; D002994:Clofibrate; D003029:Coagulants; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005340:Fibrinogen; D005342:Fibrinolysis; D005989:Glycerides; D006490:Hemostatics; D006801:Humans; D008055:Lipids / Q000097:blood*; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D013300:Streptokinase
D000924:Anticholesteremic Agents; D002087:Butyrates; D003029:Coagulants; D005989:Glycerides; D006490:Hemostatics; D008055:Lipids; D005340:Fibrinogen; D010958:Plasminogen; D002784:Cholesterol; D000738:Androsterone; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D002994:Clofibrate
ANDROSTERONE; ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS OBLITERANS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BUTYRATES; DRUG THERAPY; FIBRINOGEN; FIBRINOLYSIS; GLYCERIDES; PLASMINOGEN; STREPTODORNASE AND STREPTOKINASE